Patrick Gallagher
Corporate Officer/Principal chez SENSEI BIOTHERAPEUTICS, INC.
Fortune : 34 130 $ au 30/04/2024
Profil
Patrick Gallagher is currently the Chief Business Officer at Sensei Biotherapeutics, Inc. He previously worked as the Senior Director of Business Development at Radius Health, Inc. from 2016 to 2018.
From 2020 to 2022, he served as the Managing Director at Binney Street Partners, LLC.
Patrick also held positions at Pfizer Inc. as the Head of Sales & Marketing, AMAG Pharmaceuticals, Inc. as the Head of Business Development, and Celexion LLC as the Manager of Business Development.
Additionally, he worked as a Principal at Aquilo Partners LP from 2018 to 2020.
Patrick obtained a graduate degree in Masters of Business Administration from Boston University and an undergraduate degree from Ohio Wesleyan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/02/2023 | 34 130 ( 0,14% ) | 34 130 $ | 30/04/2024 |
Postes actifs de Patrick Gallagher
| Sociétés | Poste | Début |
|---|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2022 |
Anciens postes connus de Patrick Gallagher
| Sociétés | Poste | Fin |
|---|---|---|
| Binney Street Partners, LLC | Corporate Officer/Principal | 01/06/2022 |
Aquilo Partners LP
 Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Corporate Officer/Principal | 01/01/2020 |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01/01/2018 |
| PFIZER, INC. | Sales & Marketing | - |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Patrick Gallagher
| Boston University | Graduate Degree |
| Ohio Wesleyan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Aquilo Partners LP
Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Finance |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Celexion LLC
 Celexion LLC Pharmaceuticals: MajorHealth Technology Celexion LLC develops platform technologies and products in the pharmaceutical, industrial, agricultural and life science research sectors. The company was founded by Brian Baynes in 2009 and is headquartered in Cambridge, MA. | Health Technology |
| Binney Street Partners, LLC |
